These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 25716723)
41. How tumour cell identity is established? Sánchez-García I Semin Cancer Biol; 2015 Jun; 32():1-2. PubMed ID: 25931389 [No Abstract] [Full Text] [Related]
42. The Emerging View of Aging as a Reversible Epigenetic Process. López-León M; Goya RG Gerontology; 2017; 63(5):426-431. PubMed ID: 28538216 [TBL] [Abstract][Full Text] [Related]
43. Phases of reprogramming. David L; Polo JM Stem Cell Res; 2014 May; 12(3):754-61. PubMed ID: 24735951 [TBL] [Abstract][Full Text] [Related]
44. RNA splicing and its connection with other regulatory layers in somatic cell reprogramming. Zavolan M; Kanitz A Curr Opin Cell Biol; 2018 Jun; 52():8-13. PubMed ID: 29275148 [TBL] [Abstract][Full Text] [Related]
45. Wounds that will not heal: pervasive cellular reprogramming in cancer. Byun JS; Gardner K Am J Pathol; 2013 Apr; 182(4):1055-64. PubMed ID: 23438473 [TBL] [Abstract][Full Text] [Related]
46. Dedifferentiation and Guo Y; Wu W; Yang X; Fu X Mol Med Rep; 2022 Dec; 26(6):. PubMed ID: 36321786 [TBL] [Abstract][Full Text] [Related]
47. Cancer cells escape the immune system by increasing stemness through epigenetic reprogramming. Costoya JA; Arce VM Cell Mol Immunol; 2023 Jan; 20(1):6-7. PubMed ID: 36380095 [No Abstract] [Full Text] [Related]
48. Bcl11b and Atoh8 Coordinate Cellular Plasticity for Reprogramming and Transformation. Huang MF; Shoemaker R; Lee DF Cell Reprogram; 2022 Dec; 24(6):324-326. PubMed ID: 36409720 [TBL] [Abstract][Full Text] [Related]
49. Cisplatin-induced apoptosis and development of resistance are transcriptionally distinct processes. Panaretakis T Cell Cycle; 2012 Oct; 11(20):3723. PubMed ID: 22983001 [No Abstract] [Full Text] [Related]
51. Transcriptional profiling of apoptosis: cell death classification moves toward the systems era. Yao Z; Szabadkai G Cell Cycle; 2012 Oct; 11(20):3721-2. PubMed ID: 22982998 [No Abstract] [Full Text] [Related]
52. Conditional Reprogramming Inducing Clinical Cells Proliferation: New Research Tools in Tumor and Inflammatory-related Diseases. Chai J; Han L; Zhang J; Han D; Zou L; Zhu Z; Zhao Y; Guo H Curr Pharm Des; 2020; 26(22):2657-2660. PubMed ID: 32175833 [TBL] [Abstract][Full Text] [Related]
53. Reprogramming, in print and in person. Sweet DJ Cell Stem Cell; 2011 Dec; 9(6):487. PubMed ID: 22136916 [No Abstract] [Full Text] [Related]
57. Epigenetic regulation in stem cell development, cell fate conversion, and reprogramming. Ohbo K; Tomizawa S Biomol Concepts; 2015 Mar; 6(1):1-9. PubMed ID: 25720089 [TBL] [Abstract][Full Text] [Related]
58. Direct reprogramming of fibroblasts into cardiomyocytes for cardiac regenerative medicine. Fu JD; Srivastava D Circ J; 2015; 79(2):245-54. PubMed ID: 25744738 [TBL] [Abstract][Full Text] [Related]
59. In vivo reprogramming for tissue repair. Heinrich C; Spagnoli FM; Berninger B Nat Cell Biol; 2015 Mar; 17(3):204-11. PubMed ID: 25720960 [TBL] [Abstract][Full Text] [Related]
60. Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs). Ma N; Shan Y; Liao B; Kong G; Wang C; Huang K; Zhang H; Cai X; Chen S; Pei D; Chen N; Pan G J Biol Chem; 2015 May; 290(19):12079-89. PubMed ID: 25795783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]